Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -9.57% is 51% above its 5-year average of -19.72%, near the high end of its 5-year range (-57.31%–-4.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.64% below its 12-month average of -8.50%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -9.57%.
RETURN ON INVESTED CAPITAL (ROIC)
-9.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-8.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-19.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-19.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-12.64%
CURRENT VS 3Y AVG
+51.58%
CURRENT VS 5Y AVG
+51.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+73.15%
vs the sector median at left
10x Genomics, Inc.
Market Cap
$10.20B
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-8.50%
3Y Avg
-19.76%
5Y Avg
-19.72%
Market Cap
$10.21B
Return on Invested Capital (ROIC)
3.56%
TTM Avg
12.01%
3Y Avg
15.07%
5Y Avg
15.28%
Market Cap
$10.14B
Return on Invested Capital (ROIC)
8.90%
TTM Avg
10.00%
3Y Avg
10.19%
5Y Avg
11.72%
Market Cap
$10.12B
Return on Invested Capital (ROIC)
-45.63%
TTM Avg
-80.95%
3Y Avg
-90.71%
5Y Avg
-98.29%
Market Cap
$10.30B
Return on Invested Capital (ROIC)
10.49%
TTM Avg
5.87%
3Y Avg
5.79%
5Y Avg
6.13%
Market Cap
$10.03B
Return on Invested Capital (ROIC)
7.29%
TTM Avg
7.04%
3Y Avg
6.95%
5Y Avg
7.54%
Market Cap
$10.39B
Return on Invested Capital (ROIC)
-24.57%
TTM Avg
-32.39%
3Y Avg
-30.66%
5Y Avg
-30.79%
Market Cap
$9.93B
Return on Invested Capital (ROIC)
1.54%
TTM Avg
2.53%
3Y Avg
2.92%
5Y Avg
2.77%
Market Cap
$9.89B
Return on Invested Capital (ROIC)
1.85%
TTM Avg
0.17%
3Y Avg
2.33%
5Y Avg
3.34%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | $10.20B | -9.57% | -8.50% | -19.76% | -19.72% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 3.56% | 12.01% | 15.07% | 15.28% |
| Align Technology, Inc. (ALGN)vs › | $10.14B | 8.90% | 10.00% | 10.19% | 11.72% |
| ImmunityBio, Inc. (IBRX)vs › | $10.12B | -45.63% | -80.95% | -90.71% | -98.29% |
| Globus Medical, Inc. (GMED)vs › | $10.30B | 10.49% | 5.87% | 5.79% | 6.13% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 7.29% | 7.04% | 6.95% | 7.54% |
| Twist Bioscience Corporation (TWST)vs › | $10.39B | -24.57% | -32.39% | -30.66% | -30.79% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 1.54% | 2.53% | 2.92% | 2.77% |
| Repligen Corporation (RGEN)vs › | $9.89B | 1.85% | 0.17% | 2.33% | 3.34% |
| Universal Health Services, Inc. (UHS)vs › | $10.70B | 11.74% | 10.95% | 8.97% | 9.05% |
ROIC
-9.6%
ROE
-9.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -9.57% |
| 2026-03-31 | -4.29% |
| 2025-12-31 | -6.78% |
| 2025-09-30 | -10.25% |
| 2025-06-30 | -11.58% |
| 2025-03-31 | -21.67% |
| 2024-12-31 | -24.29% |
| 2024-09-30 | -24.48% |
| 2024-06-30 | -30.93% |
| 2024-03-31 | -33.76% |
| 2023-12-31 | -31.66% |
| 2023-09-30 | -27.64% |
| 2023-06-30 | -20.01% |
| 2023-03-31 | -19.76% |
| 2022-12-31 | -18.70% |
| 2022-09-30 | -18.48% |
| 2022-06-30 | -15.45% |
| 2022-03-31 | -9.22% |
| 2021-12-31 | -5.75% |
| 2021-09-30 | -50.10% |
| 2021-06-30 | -57.31% |
| 2021-03-31 | -62.93% |
| 2020-12-31 | -65.84% |
| 2020-09-30 | -14.79% |
| 2020-06-30 | -16.60% |
| 2020-03-31 | -8.60% |
| 2019-12-31 | -5.53% |
| 2019-09-30 | -18.32% |
| 2019-06-30 | -88.10% |
| 2018-12-31 | -106.81% |
